![Eimear Moloney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eimear Moloney
Director/Board Member at
KINGSPAN GROUP PLC
Net worth: 834 001 $ as of 31/08/2026
Profile
Ms. Eimear G.
Moloney is an Independent Non-Executive Director at Irish Continental Group Plc, an Independent Non-Executive Director at Kingspan Group Plc and a Member at Institute of Directors In Ireland.
She is on the Board of Directors at Irish Continental Group Plc, Kingspan Group Plc, De Burgo Pharma Group Ltd. and Chanelle Pharmaceuticals Manufacturing Ltd. Ms. Moloney was previously employed as an Independent Non-Executive Director by Yew Grove REIT Plc, a Senior Independent Director by Hostelworld Group Plc, and an Associate Director-Global Equities by Zurich Life Assurance Plc.
She received her undergraduate degree from Dublin City University and a graduate degree from Dublin City University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2025 | 50,000 ( 0.03% ) | 415 853 $ | 31/08/2026 | |
| 31/12/2024 | 2,000 ( 0% ) | 238 128 $ | 31/08/2026 | |
| 31/12/2025 | 1,22,376 ( 0.1% ) | 180 020 $ | 31/08/2026 |
Eimear Moloney active positions
| Companies | Position | Start |
|---|---|---|
| KINGSPAN GROUP PLC | Director/Board Member | 30/04/2021 |
| IRISH CONTINENTAL GROUP PLC | Director/Board Member | 25/08/2022 |
Institute of Directors In Ireland
 Institute of Directors In Ireland Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
Chanelle Pharma Group Ltd.
 Chanelle Pharma Group Ltd. Pharmaceuticals: GenericHealth Technology Operates as generic drug maker | Director/Board Member | 01/03/2019 |
Chanelle Pharmaceuticals Manufacturing Ltd.
 Chanelle Pharmaceuticals Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic animal pharmaceutical products | Director/Board Member | - |
Former positions of Eimear Moloney
| Companies | Position | End |
|---|---|---|
| HOSTELWORLD GROUP PLC | Director/Board Member | 23/07/2026 |
| YEW GROVE REIT PLC | Director/Board Member | 07/02/2022 |
Zurich Life Assurance Plc
 Zurich Life Assurance Plc Investment ManagersFinance Zurich Life invests globally across asset classes and does not strongly adhere to a particular investment style. They offer a wide range of funds: (1) multi-asset funds generally invest in a range of assets, countries and market sectors, diversifying the client’s investment across many different asset classes in order to minimize risk; (2) cash and bond funds; (3) equity funds; (4) property funds can give two types of return: capital growth on the value of a property, and rental income; (5) dimensional funds; and (6) alternative investment which include precious metals such as gold and copper, as well as investments in water infrastructure and agriculture. | Portfolio Manager-Equities | - |
Training of Eimear Moloney
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
55
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Kingspan Group Plc
 Kingspan Group Plc Construction MaterialsNon-Energy Minerals Manufactures insulated panels, piping insulation and ducting insulation products | Non-Energy Minerals |
Irish Continental Group Plc
 Irish Continental Group Plc Marine ShippingTransportation Operates ferries and containers & terminals | Transportation |
Zurich Life Assurance Plc
Zurich Life Assurance Plc Investment ManagersFinance Zurich Life invests globally across asset classes and does not strongly adhere to a particular investment style. They offer a wide range of funds: (1) multi-asset funds generally invest in a range of assets, countries and market sectors, diversifying the client’s investment across many different asset classes in order to minimize risk; (2) cash and bond funds; (3) equity funds; (4) property funds can give two types of return: capital growth on the value of a property, and rental income; (5) dimensional funds; and (6) alternative investment which include precious metals such as gold and copper, as well as investments in water infrastructure and agriculture. | Finance |
Chanelle Pharma Group Ltd.
Chanelle Pharma Group Ltd. Pharmaceuticals: GenericHealth Technology Operates as generic drug maker | Health Technology |
Chanelle Pharmaceuticals Manufacturing Ltd.
Chanelle Pharmaceuticals Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic animal pharmaceutical products | Health Technology |
Dublin City University
 Dublin City University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Directors In Ireland
Institute of Directors In Ireland Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Hostelworld Group Plc
 Hostelworld Group Plc Other Consumer ServicesConsumer Services Provides online hotel and hostel reservation services | Consumer Services |
Yew Grove REIT Plc
 Yew Grove REIT Plc Real Estate Investment TrustsFinance Acts as a Real Estate Investment Trust/REIT | Finance |
- Stock Market
- Insiders
- Eimear Moloney
